Powered by

Judge clears Bind Therapeutics sale to Pfizer

Jul 27, 2016 - The Deal Pipeline

Cancer treatment developer Bind Therapeutics Inc. (BIND) can sell its assets to drug company Pfizer Inc. (PFE) for $40 million.

Chief Judge Brendan Linehan Shannon of the U.S. Bankruptcy Court for the District of Delaware in Wilmington on Wednesday, July 27, signed an order approving Bind's sale a day after Pfizer won an auction to purchase the debtor's assets.

NanoCarrier Co. Ltd. was the back-up bidder at the auction, according to a notice of prevailing purchaser filed on Tues...